首页> 外文学位 >Synergistic behaviour of Salvia and Notoginseng species in vascular diseases
【24h】

Synergistic behaviour of Salvia and Notoginseng species in vascular diseases

机译:丹参和三七在血管疾病中的协同行为

获取原文
获取原文并翻译 | 示例

摘要

As the mainstay and principal form of traditional Chinese medicine (TCM), Chinese herbal medicine (CHM) has been the subject of growing interest and popular use worldwide. However, its unique philosophy, diagnosis and prescription are completely different from Western Medicine (WM), which has brought great challenges for the quality standardisation, safety control, and efficacy evaluation confronting its development in a modernised scientific manner.;This PhD project aims to address challenges that revolve around the efficacy research of CHM. Based on CHM theory, the key mechanism of the efficacy of CHM is the synergistic interactions among multiple herbal ingredients in a formula to reach an optimised therapeutic effect, multi-target mode of actions and reduced potential side effects. Several rigorous analytical methods such as combination index (CI), isobolographic analysis and systems biology are designed for the quantitative evaluations of synergistic effects in pharmaceutical combination therapy, and have also been utilised for the study of CHM. Among them, CI and isobologram models are applied for studying the interactions of a small number of active components or herbal extracts on the same target or receptor in which their chemical and pharmacological properties are well defined. A systems biology model may also be used to analyse multi-component, multi-target actions in combinational therapy. However, following a systematic review, it is apparent that the current literature on synergistic study of CHM is still at an early stage. Based on previous studies, we hypothesised that a platform to systematically analyse synergistic interactions of herbal compounds can be established by modern bioassays and scientific models (e.g., CI and isobologram approaches).;Herb-pairs are the basic unit for the Chinese herbal formulae. Salvia Miltiorrhiza Radix et Rhizoma and Notoginseng Radix et Rhizome (known as Danshen [DS] and Sanqi [SQ] in TCM) has been one of the most frequently prescribed herb pairs in TCM clinics for cardiovascular disease management for over 30 years in Asian countries. However, very limited mechanistic studies on the combinational benefits on the complex pathological mechanisms of vascular diseases are available, despite the fact that the bioactivities for a single extract have been well studied. Therefore, the DS-SQ herb-pair was selected as a case study to address the issue of synergistic activities in CHM.
机译:作为中药(TCM)的主要和主要形式,中草药(CHM)已成为世界范围内日益增长的关注和广泛使用的主题。然而,其独特的理念,诊断和处方与西医(WM)完全不同,西药在以现代化科学方式发展的过程中,对质量标准化,安全控制和功效评估提出了巨大挑战。解决围绕CHM功效研究的挑战。基于CHM理论,CHM功效的关键机制是配方中多种草药成分之间的协同相互作用,以达到最佳的治疗效果,多目标作用模式和减少的潜在副作用。设计了几种严格的分析方法,例如联合指数(CI),等效线描记法分析和系统生物学,用于定量评估药物联合治疗中的协同效应,也已用于CHM的研究。其中,CI和等效线图模型用于研究少量活性成分或草药提取物在相同靶标或受体上的相互作用,其中它们的化学和药理特性得到了很好的定义。系统生物学模型也可用于分析组合疗法中的多组分,多目标作用。然而,经过系统的审查,很明显,目前有关CHM协同研究的文献仍处于早期阶段。基于以前的研究,我们假设可以通过现代生物测定和科学模型(例如CI和等效线图法)建立一个系统分析草药化合物协同相互作用的平台。草药对是中草药配方的基本单位。丹参和三七(在中医中被称为丹参[DS]和三七[SQ])已成为亚洲国家中针对心血管疾病管理的中医诊所中最常用的草药对之一。然而,尽管对单一提取物的生物活性进行了充分的研究,但有关血管疾病的复杂病理机制的综合获益的机制研究却非常有限。因此,选择DS-SQ草药对作为案例研究,以解决CHM中的协同活性问题。

著录项

  • 作者

    Zhou, Xian.;

  • 作者单位

    Western Sydney University (Australia).;

  • 授予单位 Western Sydney University (Australia).;
  • 学科 Pharmacology.;Alternative medicine.
  • 学位 Ph.D.
  • 年度 2016
  • 页码 320 p.
  • 总页数 320
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:46:32

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号